Evidence map›Paper›PMID 29286489›Full record

ArticleJournal of visualized experiments : JoVE2017

Detection and Removal of Nuclease Contamination During Purification of Recombinant Prototype Foamy Virus Integrase.

Miguel A Lopez, Randi M Mackler, Matthew P Altman, Kristine E Yoder

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Foamy Virus Integrase in Development of Viral Vector for Gene Therapy.Journal of microbiology and biotechnology · 2020
    Review
  4. Article
  5. Article
  6. Prototype foamy virus integrase is promiscuous for target choice.Biochemical and biophysical research communications · 2018
    Article
  7. Assembly and Purification of Prototype Foamy Virus Intasomes.Journal of visualized experiments : JoVE · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Miguel A LopezDepartment of Cancer Biology and Genetics, The Ohio State University College of Medicine.
Randi M MacklerDepartment of Cancer Biology and Genetics, The Ohio State University College of Medicine.
Matthew P AltmanDepartment of Cancer Biology and Genetics, The Ohio State University College of Medicine.
Kristine E YoderDepartment of Cancer Biology and Genetics, The Ohio State University College of Medicine; yoder.176@osu.edu.
The Ohio State University · US

Funding

The Mechanics of Retroviral IntegrationR01AI126742 · NIAID · OHIO STATE UNIVERSITY · PI FISHEL, RICHARD, YODER, KRISTINE E · 2017 to 2021
$1.9M
Studies of the molecular mechanism of retroviral integrationR21AI099854 · NIAID · OHIO STATE UNIVERSITY · PI FISHEL, RICHARD, YODER, KRISTINE E · 2013 to 2014
$422k
NIAID NIH HHS R01 AI126742NIAID NIH HHS R21 AI099854
6 · The paper itself

Abstract

The integrase (IN) protein of the retrovirus prototype foamy virus (PFV) is a model enzyme for studying the mechanism of retroviral integration. Compared to IN from other retroviruses, PFV IN is more soluble and more amenable to experimental manipulation. Additionally, it is sensitive to clinically relevant human immunodeficiency virus (HIV-1) IN inhibitors, suggesting that the catalytic mechanism of PFV IN is similar to that of HIV-1 IN. IN catalyzes the covalent joining of viral complementary DNA (cDNA) to target DNA in a process called strand transfer. This strand transfer reaction introduces nicks to the target DNA. Analysis of integration reaction products can be confounded by the presence of nucleases that similarly nick DNA. A bacterial nuclease has been shown to co-purify with recombinant PFV IN expressed in Escherichia coli (E. coli). Here we describe a method to isolate PFV IN from the contaminating nuclease by heparin affinity chromatography. Fractions are easily screened for nuclease contamination with a supercoiled plasmid and agarose gel electrophoresis. PFV IN and the contaminating nuclease display alternative affinities for heparin sepharose allowing a nuclease-free preparation of recombinant PFV IN suitable for bulk biochemical or single molecule analysis of integration.

Indexed as

DeoxyribonucleasesDNA, ViralHumansIntegrasesRecombinant ProteinsSpumavirusVirus IntegrationDeoxyribonucleasesDNA, ViralIntegrasesRecombinant Proteins

Identifiers

PMID29286489
PMCPMC5755535
OpenAlexW2770016518

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.